| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7796816 | European Journal of Medicinal Chemistry | 2018 | 26 Pages |
Abstract
The myeloid cell leukemia 1 (Mcl-1) protein has emerged as an attractive target for the development of anti-cancer therapy. This review highlights recent advances in the discovery of small-molecule Mcl-1 inhibitors from 2012 to 2017.241
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yichao Wan, Ningning Dai, Zilong Tang, Hao Fang,